Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD)
This study has been completed.
Sponsors and Collaborators: Groupe Hospitalier Pitie-Salpetriere
Assistance Publique - Hôpitaux de Paris
Information provided by: Groupe Hospitalier Pitie-Salpetriere
ClinicalTrials.gov Identifier: NCT00169377
  Purpose

Obsessive-compulsive disorder is a disabling and frequent disorder. In some patients, the medical treatment is ineffective. The pathophysiology of this disease is still unknown. Some data suggest that basal ganglia dysfunction could participate in the occurrence of OCD. The aim of this study is to evaluate the efficacy of subthalamic nucleus high-frequency stimulation in patients with severe OCD.


Condition Intervention Phase
Obsessive Compulsive Disorder
Procedure: deep brain stimulation
Procedure: Off
Phase I
Phase II

MedlinePlus related topics: Obsessive-Compulsive Disorder
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Efficacy Study
Official Title: Study of the Effects of High Frequency Stimulation of the Subthalamic Stimulation in the Treatment of Severe Obsessive-Compulsive Disorders

Further study details as provided by Groupe Hospitalier Pitie-Salpetriere:

Primary Outcome Measures:
  • YBOCS [ Time Frame: 2 three-month periods ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • MOCI, BABS, CGI, MADRS, HAD, GAF, SAS, neuropsychological tests, SAS-SR, Adverse event [ Time Frame: 10 month follow-up but 2 3-month period for the cross-over ] [ Designated as safety issue: Yes ]

Enrollment: 16
Study Start Date: October 2005
Study Completion Date: May 2007
Arms Assigned Interventions
A: Active Comparator
Stimulator on followed by off
Procedure: deep brain stimulation
Stimulator on followed by off
B: Sham Comparator
Stimulator off followed by on
Procedure: Off
Stimulator off followed by on

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Severe obsessive-compulsive disorder

Exclusion Criteria:

  • Contraindication to magnetic resonance imaging (MRI)
  • Severe cognitive or behavioral disorders
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00169377

Locations
France
Centre d'Investigation Clinique-Hôpital Pitié-Salpêtrière
Paris, France
Bordeaux, France
Clermont-Ferrand, France
Grenoble, France
Nantes, France
Saint-Anne
Paris, France
Poitiers, France
Rennes, France
Toulouse, France
Nice, France
Sponsors and Collaborators
Groupe Hospitalier Pitie-Salpetriere
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: Luc Mallet, MD, PhD Assistance Publique - Hôpitaux de Paris
  More Information

Publications indexed to this study:
Responsible Party: Assistance Publique - Hôpitaux de Paris Delegation Research Clinical ( cecile Jourdain )
Study ID Numbers: P030422
Study First Received: September 12, 2005
Last Updated: July 22, 2008
ClinicalTrials.gov Identifier: NCT00169377  
Health Authority: France: Ministry of Health

Keywords provided by Groupe Hospitalier Pitie-Salpetriere:
Obsessive compulsive disorder
deep brain stimulation
subthalamic nucleus

Study placed in the following topic categories:
Anxiety Disorders
Mental Disorders
Obsessive-Compulsive Disorder

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 13, 2009